[3-(3-isopropyl-1,2,4-oxadiazol-5-yl)propyl]amine, 95.0%, 250mg

EDTA magnesium disodium salt x H2O, min. 90%, for synthesis, 250 g, plastic packaging.

3-Methoxytetrahydrothiophene 1,1-Dioxide>99.0%(GC)5g

Mono-6-(Fmoc-Gln-OtBu)-beta-CD>85.0%(HPLC)100mg

5-(Benzyloxy)-2-bromopyridine, 95.0%, 1g

N-methoxy-N-methyl-2H-1,3-benzodioxole-5-carboxamide, 95.0%, 1g

5-Hydroxy-1-methyl-1H-pyrazole>98.0%(GC)1g

2-Chloro-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one, 95.0%, 250mg

N,N-Dimethylnaphthalen-2-amine, 97%, 5g

1,1,1,2,2,4,5,5,5-Nonafluoro-4-(trifluoromethyl)-3-pentanone>98.0%(GC)100g

2-Chlorobenzo[d]thiazole-7-carboxylic acid, 95.0%, 1g

2-Cyclohexyl-D-glycine, 97.0%, 25g

Boc-Asp-NH2, 95.0%, 5g